← Back to Clinical Trials
Recruiting NCT06746428

NCT06746428 Activity Coaching During Pelvic Radiation Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06746428
Status Recruiting
Phase
Sponsor Inova Health Care Services
Condition Radiation Therapy
Study Type INTERVENTIONAL
Enrollment 16 participants
Start Date 2025-01-27
Primary Completion 2026-07-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Exercise Coaching

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 16 participants in total. It began in 2025-01-27 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Research has shown that for women who are undergoing pelvic radiation therapy, fatigue is a common side effect. Fatigue that occurs during radiation therapy can make it harder to perform daily living activities. While there are studies that recommend exercise as a treatment for fatigue in cancer patients and survivors, there are currently no studies that focus on the role of exercise for women undergoing pelvic radiation therapy. The purpose of this study is to see if incorporating an activity coaching program is helpful in improving treatment-related fatigue for women undergoing pelvic radiation therapy for endometrial cancer.

Eligibility Criteria

Inclusion Criteria: * At least 18 years of age * Pathologic diagnosis of endometrial cancer (any histology, Stage I-IVA) * Has undergone modified radical or radical hysterectomy * Plan to receive adjuvant treatment with pelvic external beam radiation therapy at ISCI * ECOG performance status of 0-1 * Patient has a computer, smart phone, or tablet virtual access to the web-based platform and email * Able to read, understand and provide written informed consent * Deemed appropriate for unmonitored exercise by treating physician based on the following evidence-based criteria (1) * Walk without any assistance or assistance device * Absence of significant cognitive impairment * Absence of high risk for falls * Participant does not need to refrain from any activity Exclusion Criteria: * Unable to schedule and attend coaching visits * Participation in a regular exercise program of ≥150 minutes of moderate intensity exercise a week at baseline * Unable to perform the five-times stand test * Medical comorbidities including: * Unstable angina * Uncontrolled dysrhythmias * Acute pulmonary embolus * Active pulmonary infection

Contact & Investigator

Central Contact

Melissa Miller, PhD

✉ activate@inova.org

📞 (571) 472-4724

Principal Investigator

Avani Rao, MD

PRINCIPAL INVESTIGATOR

Inova Health Care Services

Frequently Asked Questions

Who can join the NCT06746428 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Radiation Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06746428 currently recruiting?

Yes, NCT06746428 is actively recruiting participants. Contact the research team at activate@inova.org for enrollment information.

Where is the NCT06746428 trial being conducted?

This trial is being conducted at Alexandria, United States, Fairfax, United States, Fairfax, United States, Leesburg, United States.

Who is sponsoring the NCT06746428 clinical trial?

NCT06746428 is sponsored by Inova Health Care Services. The principal investigator is Avani Rao, MD at Inova Health Care Services. The trial plans to enroll 16 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology